Among people with HIV (PWH), markers of immune dysregulation and heightened inflammation, such as interleukin 6 (IL-6) and soluble tumor necrosis factor receptor I (sTNFR-I), are associated with adverse clinical outcomes, including cardiovascular disease, cognitive decline, frailty, and mortality [1–3]. The gene discussed is IL6; the disease is cardiovascular disorder.